Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Dilemma of Antiepileptic Drugs Withdrawal in Symptomatic Epilepsy (CROSBI ID 183483)

Prilog u časopisu | prethodno priopćenje

Šepić Grahovac, Dubravka ; Bajek, Goran ; Vitezić, Dinko ; Tuškan Mohar, Lidija ; Ružić Baršić, Antonija ; Grahovac, Tanja ; Bajek, Snježana Dilemma of Antiepileptic Drugs Withdrawal in Symptomatic Epilepsy // Collegium antropologicum, 35 (2011), 4; 1291-1294

Podaci o odgovornosti

Šepić Grahovac, Dubravka ; Bajek, Goran ; Vitezić, Dinko ; Tuškan Mohar, Lidija ; Ružić Baršić, Antonija ; Grahovac, Tanja ; Bajek, Snježana

engleski

Dilemma of Antiepileptic Drugs Withdrawal in Symptomatic Epilepsy

A successful treatment of epilepsy depends on numerous factors such as etiology, genetics and environmental impact. An exact diagnosis, treatment and an adequate selection of antiepileptic drugs (AED) are important from the very beginning. The patient with symptomatic epilepsy caused by the brain tumor (low-grade astrocytoma in the left parietal lobe, surgically removed 17 years after the first manifestation of illness) is presented in this study. He has been seizure free for 6 years. The represented case study deals with the risk-benefit analysis of the discontinuation of the prescribed antiepileptic treatment that has lasted for 23 years.

epilepsy; brain tumor; antiepileptic drugs; withdrawal

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

35 (4)

2011.

1291-1294

objavljeno

0350-6134

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost